Morgan Stanley’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $387 | Sell |
|
|||||
|
2024
Q3 | $5.14K | Sell |
|
|||||
|
2024
Q2 | $50K | Sell |
|
|||||
|
2024
Q1 | $93.4K | Buy |
|
|||||
|
2023
Q4 | $25.2K | Sell |
|
|||||
|
2023
Q3 | $18.6K | Sell |
|
|||||
|
2023
Q2 | $20.7K | Sell |
|
|||||
|
2023
Q1 | $34.7K | Buy |
|
|||||
|
2022
Q4 | $24.6K | Sell |
|
|||||
|
2022
Q3 | $62K | Sell |
|
|||||
|
2022
Q2 | $95K | Buy |
|
|||||
|
2022
Q1 | $95K | Buy |
|
|||||
|
2021
Q4 | $227K | Sell |
|
|||||
|
2021
Q3 | $1.02M | Sell |
|
|||||
|
2021
Q2 | $2.2M | Buy |
|
|||||
|
2021
Q1 | $2.8M | Buy |
|
|||||
|
2020
Q4 | $822K | Buy |
|
|||||
|
2020
Q3 | $68K | Sell |
|
|||||
|
2020
Q2 | $252K | Buy |
|
|||||
|
2020
Q1 | $33K | Sell |
|
|||||
|
2019
Q4 | $355K | Buy |
|
|||||
|
2019
Q3 | $105K | Buy |
|
|||||
|
2019
Q2 | $12K | Sell |
|
|||||
|
2019
Q1 | $47K | Sell |
|
|||||
|
2018
Q4 | $218K | Sell |
|
|||||
|
2018
Q3 | $554K | Sell |
|
|||||
|
2018
Q2 | $556K | Buy |
|
|||||
|
2018
Q1 | $492K | Buy |
|
|||||
|
2017
Q4 | $265K | Buy |
|
|||||
|
2017
Q3 | $392K | Buy |
|
|||||
|
2017
Q2 | $235K | Buy |
|
|||||
|
2017
Q1 | $173K | Sell |
|
|||||
|
2016
Q4 | $377K | Sell |
|
|||||
|
2016
Q3 | $469K | Buy |
|